 |
|
| |
 |
Rubicon Global Research provides comprehensive
intelligence on public
companies. Our service offering provides two-levels
of research, made
available to both institutional as well as retail
investors on both a
per-report fee or subscription basis.
Rubicon Global Research is not compensated by
the companies we cover, nor do
we offer investment banking or trading activities.
We are an independent
research service (see select disclosures on
each report for more detail).
Our services include both full investment reports
as well as broad coverage
on specific drug events within the biotechnology
marketplace. You will find
that our research provides innovative analysis
on a timely basis.
Our full investment reports cover a company
in detail that supports an
investment recommendation. We deliver key insights
about small, undiscovered
companies that delineate excellent opportunities
for investors.
In the search for opportunities, we discover
and recognize new services,
products, innovative technology, and dynamic
marketing initiatives among
today?s promising companies.
Our unique healthcare coverage provides a comprehensive
view on upcoming
drug events. Each report focuses on a specific
drug, the event, the
expectation, competition and market opportunity.
|
|
|
|
